International Journal of High Risk Behaviors and Addiction

Published by: Kowsar

Investigating the Trend and Severity of Withdrawal Symptoms in Methamphetamine Users Amongst Homeless Addicts

Yousef Khani 1 , Hojatoolah Barati 1 , Abolfaz Mollajan 1 , Mahshid Mojtahedzadeh Faghihi 2 and Shahnaz Rimaz 3 , *
Authors Information
1 Deputy of Health, Alborz University of Medical Sciences, Karaj, IR Iran
2 Department of Psychology, International Campus of Kharazmi University, Karaj, IR Iran
3 Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, IR Iran
Article information
  • International Journal of High Risk Behaviors and Addiction: March 2018, 7 (1); e66880
  • Published Online: February 13, 2018
  • Article Type: Research Article
  • Received: April 27, 2016
  • Revised: February 15, 2017
  • Accepted: April 24, 2017
  • DOI: 10.5812/ijhrba.66880

To Cite: Khani Y, Barati H, Mollajan A, Mojtahedzadeh Faghihi M, Rimaz S. et al. Investigating the Trend and Severity of Withdrawal Symptoms in Methamphetamine Users Amongst Homeless Addicts, Int J High Risk Behav Addict. 2018 ;7(1):e66880. doi: 10.5812/ijhrba.66880.

Abstract
Copyright © 2018, International Journal of High Risk Behaviors and Addiction. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
References
  • 1. Costa e Silva JA. Evidence-based analysis of the worldwide abuse of licit and illicit drugs. Hum Psychopharmacol. 2002;17(3):131-40. doi: 10.1002/hup.378. [PubMed: 12404690].
  • 2. Cruickshank CC, Dyer KR. A review of the clinical pharmacology of methamphetamine. Addiction. 2009;104(7):1085-99. doi: 10.1111/j.1360-0443.2009.02564.x. [PubMed: 19426289].
  • 3. United Nations Office on Drugs and Crime (UNODC) . World Drug Report 2010. United Nations publication, Sales No E.10.XI.13; 2010.
  • 4. United Nations Office on Drugs and Crime (UNODC) . World Drug Report 2014. United Nations publication, Sales No. E.14.XI.7; 2014.
  • 5. Moharreri MR. The International Challenge of Drug Abuse. General view of drug abuse in Iran, and a one-year report of out- patient treatment of opiate addiction in the city of Shiraz. Rockville: NIDA Research Monograph 19; 1978.
  • 6. Narenjiha H, Rafiey H, Baghestani AH. Rapid situation assessment of drug abuse and drug dependence in Iran. Tehran: Darius Institute; 2005.
  • 7. Barooni S, Mehrdad R, Akbari E. A survey of Ecstasy use among 15-25 year-olds in five areas of Tehran [In Persian]. Tehran Univ Med J. 2008;65(11):49-54.
  • 8. Mohtasham-Amiri Z, Jafari-Shakib A, Khalili-Moosavi A. Prevalence and factors associated with Ecstasy use among college undergraduates in north of Iran-2005. Asian J Psychiatr. 2011;4(1):31-4. doi: 10.1016/j.ajp.2011.01.004. [PubMed: 23050911].
  • 9. Moasheri N, Miri M, Mashreghi Moghadam HM, Eslami MR. A Study of Birjand University students' knowledge and attitude towards taking Ecstasy pills [In Persian]. J Birjand Univ Med Sci. 2007;13(4):9-15.
  • 10. Barati M, Allahverdipour H, Jalilian F. Prevalence and predictive factors of psychoactive and hallucinogenic substance abuse among college students [In Persian]. J Fund Ment Health. 2012;13(4):347-83.
  • 11. Kulsudjarit K. Drug problem in southeast and southwest Asia. Ann N Y Acad Sci. 2004;1025:446-57. doi: 10.1196/annals.1316.055. [PubMed: 15542748].
  • 12. Samii AW. Drug abuse: Iran's 'thorniest problem'. Brown J World Aff. 2003;9(2):283.
  • 13. Murray JB. Psychophysiological aspects of amphetamine-methamphetamine abuse. J Psychol. 1998;132(2):227-37. doi: 10.1080/00223989809599162. [PubMed: 9529666].
  • 14. Brecht ML, von Mayrhauser C, Anglin MD. Predictors of relapse after treatment for methamphetamine use. J Psychoactive Drugs. 2000;32(2):211-20. doi: 10.1080/02791072.2000.10400231. [PubMed: 10908010].
  • 15. Koob GF, Le Moal M. Review. Neurobiological mechanisms for opponent motivational processes in addiction. Philos Trans R Soc Lond B Biol Sci. 2008;363(1507):3113-23. doi: 10.1098/rstb.2008.0094. [PubMed: 18653439].
  • 16. Newton TF, De La Garza R2, Kalechstein AD, Tziortzis D, Jacobsen CA. Theories of addiction: methamphetamine users' explanations for continuing drug use and relapse. Am J Addict. 2009;18(4):294-300. doi: 10.1080/10550490902925920. [PubMed: 19444733].
  • 17. Robinson TE, Berridge KC. Review. The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci. 2008;363(1507):3137-46. doi: 10.1098/rstb.2008.0093. [PubMed: 18640920].
  • 18. Srisurapanont M, Ali R, Marsden J, Sunga A, Wada K, Monteiro M. Psychotic symptoms in methamphetamine psychotic in-patients. Int J Neuropsychopharmacol. 2003;6(4):347-52. doi: 10.1017/S1461145703003675. [PubMed: 14604449].
  • 19. Klee H. Amphetamine Misuse. Amphetamine misusers in contemporary Britain: The emergence of a hiddenpopulation: International Perspectiveson Current trends. In: Klee H, editor. Amsterdam: Harwood Academic Publishers; 1997.
  • 20. Gossop MR, Bradley BP, Brewis RK. Amphetamine withdrawal and sleep disturbance. Drug Alcohol Depend. 1982;10(2-3):177-83. doi: 10.1016/0376-8716(82)90010-2. [PubMed: 7166130].
  • 21. Srisurapanont M, Jarusuraisin N, Jittiwutikan J. Amphetamine withdrawal: I. Reliability, validity and factor structure of a measure. Aust N Z J Psychiatry. 1999;33(1):89-93. doi: 10.1046/j.1440-1614.1999.00517.x. [PubMed: 10197890].
  • 22. Churchill AC, Burgess PM, Pead J, Gill T. Measurement of the severity of amphetamine dependence. Addiction. 1993;88(10):1335-40. doi: 10.1111/j.1360-0443.1993.tb02019.x. [PubMed: 8251870].
  • 23. McGregor C, Srisurapanont M, Jittiwutikarn J, Laobhripatr S, Wongtan T, White JM. The nature, time course and severity of methamphetamine withdrawal. Addiction. 2005;100(9):1320-9. doi: 10.1111/j.1360-0443.2005.01160.x. [PubMed: 16128721].
  • 24. McGregor C, Srisurapanont M, Mitchell A, Longo MC, Cahill S, White JM. Psychometric evaluation of the Amphetamine Cessation Symptom Assessment. J Subst Abuse Treat. 2008;34(4):443-9. doi: 10.1016/j.jsat.2007.05.007. [PubMed: 17629443].
  • 25. World Health Organization . Process of translation and adaptation of instruments. World Health Organization; 2010.
  • 26. Waltz CF, Strickland OL, Lenz ER. Measurement in nursing and health research. Springer Publishing Company; 2010.
  • 27. Bagheri M, Mokri A, Khosravi A, Kabir K. Effect of Abstinence on Depression, Anxiety, and Quality of Life in Chronic Methamphetamine Users in a Therapeutic Community. Int J High Risk Behav Addict. 2015;4(3). e23903. doi: 10.5812/ijhrba.23903. [PubMed: 26495258].
  • 28. Zorick T, Nestor L, Miotto K, Sugar C, Hellemann G, Scanlon G, et al. Withdrawal symptoms in abstinent methamphetamine-dependent subjects. Addiction. 2010;105(10):1809-18. doi: 10.1111/j.1360-0443.2010.03066.x. [PubMed: 20840201].
  • 29. Elkashef A, Vocci F, Hanson G, White J, Wickes W, Tiihonen J. Pharmacotherapy of methamphetamine addiction: an update. Subst Abus. 2008;29(3):31-49. doi: 10.1080/08897070802218554. [PubMed: 19042205].
  • 30. Hartz DT, Frederick-Osborne SL, Galloway GP. Craving predicts use during treatment for methamphetamine dependence: a prospective, repeated-measures, within-subject analysis. Drug Alcohol Depend. 2001;63(3):269-76. doi: 10.1016/S0376-8716(00)00217-9. [PubMed: 11418231].
  • 31. Rawson RA, Huber A, Brethen P, Obert J, Gulati V, Shoptaw S, et al. Status of methamphetamine users 2-5 years after outpatient treatment. J Addict Dis. 2002;21(1):107-19. doi: 10.1300/J069v21n01_09. [PubMed: 11831496].
  • 32. Watson R, Hartmann E, Schildkraut JJ. Amphetamine withdrawal: affective state, sleep patterns, and MHPG excretion. Am J Psychiatry. 1972;129(3):263-9. doi: 10.1176/ajp.129.3.263. [PubMed: 4340897].
  • 33. Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R, et al. Risk factors for suicide attempts in methamphetamine-dependent patients. Am J Addict. 2008;17(1):24-7. doi: 10.1080/10550490701756070. [PubMed: 18214719].
  • 34. Leventhal AM, Kahler CW, Ray LA, Stone K, Young D, Chelminski I, et al. Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder. Am J Addict. 2008;17(3):218-23. doi: 10.1080/10550490802019774. [PubMed: 18463999].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments